Kemin has completed construction of a manufacturing facility for MicroPEARLS encapsulated amino acids at its global headquarters in Des Moines, Iowa.
The new $3 million facility will manufacture the company’s encapsulated lysine, marketed under the name LysiPEARL. “Our decision to build a facility in Des Moines was an investment in our customers,” said Kemin President and CEO Dr. Chris Nelson. “For several years, we have supplied dairies worldwide with LysiPEARL manufactured at our facility in Italy. Our expanded manufacturing capacity in Des Moines will allow us to meet the growing need for bypass amino acids in dairy cattle, particularly in North America.”